5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025
According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all female cancers. The early manifestation of cervical cancer are vaginal bleeding after sexual intercourse with excruciating pain. The 2 main types of cervical cancer are squamous cell carcinoma and adenocarcinoma. Early diagnosis and vaccination with Gardasil can prevent the advent of cervical cancer. In the last decade there has been a paradigm shift in the treatment regimen from chemotherapy to targeted therapy. Biologics in the phase III clinical trials such as nimotuzumab and atezolizumab will provide a positive thrust to the cervical cancer treatment market growth.
Get Sample: https://www.credenceresearch.com/sample-request/59521
Browse the full report Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/cervical-cancer-treatment-market
Chemotherapy is reigning the product segment for cervical cancer treatment market. Placitaxel, cisplatin, carboplatin, gemcitabine are given either alone or in combination with radiation therapy for patients suffering with advanced stage cervical cancer. The combination therapy is helpful but causes severe adverse effects. Cervical hysterectomy is helpful in women suffering with early stage cervical cancer. Targeted drug therapy will be the fastest growing market on account of its excellent clinical outcomes, dose tolerability and patient compliance.
North America presently maintains supremacy in the regional segment for cervical cancer treatment market. According to Center for Disease Control And Prevention (CDC), cervical cancer is the second most common type of cancer in women after breast cancer resulting in mortality due to lack of early screening and medical intervention. Rising public health awareness and affordable reimbursement scenario drive the cervical cancer treatment market growth in North America. In Europe cervical cancer is responsible for the mortality of 70% patient actively diagnosed with cervical cancer. Presence of key players such as F.Hoffman La-Roche AG., Merck & Co., Inc., and GlaxoSmithkline, Plc. etc. propel the cervical cancer treatment market growth in the European Region. Asia Pacific will be the fastest growing market during the forecast period owing to the presence of huge generic market and proactive government policies to fight cervical cancer.
Biopharmaceutical companies having a strong foothold in the cervical cancer treatment market are, Allergan, Plc., Biocon Ltd., CooperSurgical, Inc., Eli Lilly & Company, F.Hoffman La-Roche AG, GlaxoSmithkline Plc., Ethicon, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and Varian Medical Systems, Inc.
Key Market Movements:
Increasing cases of women being diagnosed for cervical cancer throughout the globe
Rising public health awareness and affordable reimbursement scenario for the generic drugs employed for the treatment of cervical cancer
Vaccination such as Gardasil is helpful in prevention of HPV infection and strong biologics pipeline with drugs in phase III clinical trials such as nimotuzumab and atezolizumab
Get Sample: https://www.credenceresearch.com/sample-request/59521
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
105 N 1st ST #429, SAN JOSE,
CA 95103, United States
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025 here
News-ID: 1510581 • Views: 360
More Releases from Acute Market Reports
Target Market for Mobile Travel Booking is gaining huge growth in upcoming years …
The mobile travel booking market was valued at US$ 858.0 Mn in 2018 and is set to grow with a CAGR of 12.2% during the forecast period. Market Insights The global market for mobile travel bookings is driven by the increasing adoption of mobile apps for a wide range of applications among consumers. Since the rise of smartphones, the market for mobile apps has changed considerably. The convenience and features offered by
Bronchitis Treatment Market Size, Share, Growth Is Expected To Reach US$ 4,606.3 …
According to the latest report published by Credence Research, Inc. “Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global Bronchitis Treatment market was valued at USD 3,345.8 Mn in 2017, and is expected to reach USD 4,606.3 Mn by 2026, expanding at a CAGR of 4.9% from
Floating Solar Panels Market: Global Industry Share, Market Trends and Forecast …
According to a new market report published by Credence Research Global Floating Solar Panels Market- Growth, Future Prospects & Competitive Analysis, 2016 - 2023, the Global Floating Solar Panels Market is expected to reach US$ 842.0 Mn by 2023, expanding at a CAGR of 65.1% during the forecast period 2016 to 2023. Browse the full Global Floating Solar Panels Market by Product Type, Location and Geography - Growth, Future Prospects &
Molecular Diagnostics Market: Global Market Share, Size, Industry Approaches, St …
Molecular Diagnostics Market - Market Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global molecular diagnostics market was valued at US$ 6,077.9 Mn in 2016, and is expected to reach US$ 12,358.6 Mn by 2025 expanding at a CAGR of 7.8 % from 2017 to 2025. View Full Report with TOC @ http://www.acutemarketreports.com/report/molecular-diagnostics-market Market Insights Molecular diagnostics has undergone tremendous technological advancement due to the growing need for personalized medication, rapid diagnosis
More Releases for Cervical
Cervical Cancer Epidemiology Insights to 2025
Publisher " Cervical Cancer - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Cervical Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Cervical Cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical
Cervical Pillows Market- Future Scope Outlook 2025
Global Cervical Pillows Market: Snapshot The global market for cervical pillows is expanding on account of the rising awareness amongst the people about the medical benefits of using these pillows. The incidence of spinal disorders has increased in recent times, thus, leading to the popularity of cervical pillows. A pinched nerve, disc sickness, herniated disc, and other similar disorders have become widespread, and hence, medical practitioners have started recommending cervical pillows
Cervical Cancer Diagnostic Tests Market
A new market research report has been recently published by Transparency Market Research, a global market intelligence firm, and made available on the company website. The research study talks about the current scenario of global cervical cancer diagnosis tests market, along with the growth prospects of the market. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”
India Cervical Cancer Screening Market Outlook 2022
Cervical cancer is an important area of action for any cancer control programme because of the burden of disease, and the potential for effective prevention through screening. Cervical cancer hardly presents any symptoms in its early stages and it highlights the importance of regular screening for the disease. Screening is looking for cancer before a person has any symptoms. This can help to find the cancer at an early stage.
Cervical Dysplasia Market Insights & Growth Prospects 2024
Global Cervical Dysplasia Market: Scope and Methodology This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. Read the Upcoming Trends and Forecast of Cervical Dysplasia Market: http://www.transparencymarketresearch.com/cervical-dysplasia-market.html The research is a combination of primary and secondary research. Primary research formed the bulk of our research
Cervical Cancer Screening Market in North America
Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America report published by Renub Research provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population. Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated